Advancing cancer therapies: assessing quality of life and patient-centred outcomes in modern cancer care
British Journal of Nursing · 2026-11-05 · 35 (20) · 1010-1015
DOI: 10.12968/bjon.2025.0439 ↗Abstract
Recent years have witnessed significant advances in cancer therapies, enhancing survival outcomes for many. Therapies have become increasingly targeted in their mechanism of action; however, they may have distinct treatment-related adverse events when compared to traditional chemotherapy. Furthermore, some adverse events are still to be fully explored. To optimise safe and effective care and patient experiences, further investigation of individuals’ experiences of these new cancer treatments is required, particularly regarding the impact on quality of life (QoL). This article highlights the need to incorporate patient-reported outcome measures, notably QoL and health-related QoL, in both cancer nursing research and practice to enhance quality, safety and patient experience and to ensure that patients are at the heart of decision-making. Information derived from these assessments can generate knowledge about individuals’ treatment experiences and, in doing so, inform care planning and decisions and, thus, potentially improve outcomes in relation to symptoms, health-related QoL, patient satisfaction and patient, physician and nurse communication.
EUVIMED